Incyte Corp (INCY)
70.35
-0.70
(-0.99%)
USD |
NASDAQ |
Nov 21, 16:00
70.35
0.00 (0.00%)
After-Hours: 18:51
Incyte Market Cap: 13.55B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 13.69B |
| November 19, 2024 | 13.59B |
| November 18, 2024 | 14.83B |
| November 15, 2024 | 14.62B |
| November 14, 2024 | 14.97B |
| November 13, 2024 | 15.50B |
| November 12, 2024 | 15.52B |
| November 11, 2024 | 15.71B |
| November 08, 2024 | 16.06B |
| November 07, 2024 | 15.86B |
| November 06, 2024 | 15.60B |
| November 05, 2024 | 14.89B |
| November 04, 2024 | 14.59B |
| November 01, 2024 | 14.67B |
| October 31, 2024 | 14.28B |
| October 30, 2024 | 14.24B |
| October 29, 2024 | 14.18B |
| October 28, 2024 | 12.66B |
| October 25, 2024 | 12.54B |
| October 24, 2024 | 12.57B |
| October 23, 2024 | 12.56B |
| October 22, 2024 | 12.64B |
| October 21, 2024 | 12.58B |
| October 18, 2024 | 12.80B |
| October 17, 2024 | 12.81B |
| Date | Value |
|---|---|
| October 16, 2024 | 12.76B |
| October 15, 2024 | 12.78B |
| October 14, 2024 | 12.62B |
| October 11, 2024 | 12.75B |
| October 10, 2024 | 12.60B |
| October 09, 2024 | 12.68B |
| October 08, 2024 | 12.67B |
| October 07, 2024 | 12.68B |
| October 04, 2024 | 13.01B |
| October 03, 2024 | 12.93B |
| October 02, 2024 | 13.04B |
| October 01, 2024 | 13.12B |
| September 30, 2024 | 12.74B |
| September 27, 2024 | 12.68B |
| September 26, 2024 | 12.54B |
| September 25, 2024 | 12.18B |
| September 24, 2024 | 12.27B |
| September 23, 2024 | 12.35B |
| September 20, 2024 | 12.66B |
| September 19, 2024 | 12.87B |
| September 18, 2024 | 12.55B |
| September 17, 2024 | 12.79B |
| September 16, 2024 | 12.79B |
| September 13, 2024 | 12.24B |
| September 12, 2024 | 12.20B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.98B
Minimum
Jul 05 2024
23.92B
Maximum
Jul 20 2020
16.30B
Average
16.43B
Median
Aug 17 2022
Market Cap Benchmarks
| Pfizer Inc | 142.44B |
| Biomarin Pharmaceutical Inc | 12.09B |
| Syndax Pharmaceuticals Inc | 1.331B |
| Allogene Therapeutics Inc | 442.41M |
| Arcutis Biotherapeutics Inc | 1.199B |
Market Cap Related Metrics
| PE Ratio | 502.50 |
| PS Ratio | 3.744 |
| Price to Book Value | 4.274 |
| Price to Free Cash Flow | 908.24 |
| Price | 70.35 |
| Earnings Yield | 0.20% |
| Operating PE Ratio | 2512.39 |